UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.131-4, Article 131

2023

Volltextzugriff (PDF)

Utility of bone marrow aspirate and biopsy in staging of patients with T-cell lymphoma in the PET-Era - tissue remains the issue

Leukemia & lymphoma, 2020-11, Vol.61 (13), p.3226-3233

2020

Volltextzugriff (PDF)

Abstract PO2-20-12: Breast Implant-associated Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-20-12-PO2-20-12

2024

Volltextzugriff (PDF)

Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era

Blood, 2019-11, Vol.134 (Supplement_1), p.4039-4039

2019

Volltextzugriff (PDF)

Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Cell Lymphoma- a Single Center Experience

Blood, 2019-11, Vol.134 (Supplement_1), p.4058-4058

2019

Volltextzugriff (PDF)

A Case of Symptomatic Supratherapeutic International Normalized Ratio on Rivaroxaban

Curēus (Palo Alto, CA), 2023-06

2023

Volltextzugriff (PDF)

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

Proceedings - Baylor University. Medical Center, 2023, Vol.36 (2), p.240-242

2023

Volltextzugriff (PDF)

Predictors of Outcomes in Older Patients with Myelofibrosis – a Subset Analysis of the CIBMTR Database

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S409-S410

2024

Volltextzugriff (PDF)

DNMT3A and TET2 mutant Clonal Hematopoiesis May Drive a Proinflammatory State and Predict Enhanced Response to Immune Checkpoint Inhibitors

Blood, 2021-11, Vol.138 (Supplement 1), p.4295-4295

2021

Volltextzugriff (PDF)

Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy

Curēus (Palo Alto, CA), 2022-12

2022

Volltextzugriff (PDF)

Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10605-10605

2021

Volltextzugriff (PDF)

Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.135-136

2022

Volltextzugriff (PDF)

Clonal Hematopoiesis in Patients Receiving Immune Checkpoint Inhibitor Therapy

Blood, 2020-11, Vol.136 (Supplement 1), p.15-16

2020

Volltextzugriff (PDF)

Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)

Blood, 2020-11, Vol.136 (Supplement 1), p.35-36

2020

Volltextzugriff (PDF)

Carfilzomib-Induced Tumor Lysis Syndrome and Biventricular Heart Failure in a Patient With Multiple Myeloma

Curēus (Palo Alto, CA), 2023-01

2023

Volltextzugriff (PDF)

Tocilizumab for CRS Prophylaxis in Haploidentical Peripheral Stem Cell Transplantation

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S124-S124

2024

Volltextzugriff (PDF)

Ponatinib-Induced Cerebrovascular Accident (CVA)

Curēus (Palo Alto, CA), 2022-12

2022

Volltextzugriff (PDF)

Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome

Curēus (Palo Alto, CA), 2023-03

2023

Volltextzugriff (PDF)

Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.131-131

2023

Volltextzugriff (PDF)

Mutant PPM1D - and TP53 -Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy

JCO precision oncology, 2022-01, Vol.6 (6), p.e2100309

2022

Volltextzugriff (PDF)

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

Baylor University Medical Center Proceedings, 2023, Vol.36 (2), p.240-242

2023

Volltextzugriff (PDF)

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

Proceedings (Baylor University. Medical Center), 2023, Vol.36 (2), p.240-242

2023

Volltextzugriff (PDF)

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

Nature biotechnology, 2019-10, Vol.37 (10), p.1137-1144

2019

Volltextzugriff (PDF)

Evidence for the Use of Acellular Dermal Matrix in Implant-Based Breast Reconstruction

Seminars in plastic surgery, 2019-11, Vol.33 (4), p.229-235

2019

Volltextzugriff (PDF)

Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models

Anti-cancer agents in medicinal chemistry, 2014-01, Vol.14 (7), p.1031-1041

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Utility of bone marrow aspirate and biopsy in staging of patients with T-cell lymphoma in the PET-Era - tissue remains the issue

Abstract PO2-20-12: Breast Implant-associated Squamous Cell Carcinoma

Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era

Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Cell Lymphoma- a Single Center Experience

A Case of Symptomatic Supratherapeutic International Normalized Ratio on Rivaroxaban

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

Predictors of Outcomes in Older Patients with Myelofibrosis – a Subset Analysis of the CIBMTR Database

DNMT3A and TET2 mutant Clonal Hematopoiesis May Drive a Proinflammatory State and Predict Enhanced Response to Immune Checkpoint Inhibitors

Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy

Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure

Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia

Clonal Hematopoiesis in Patients Receiving Immune Checkpoint Inhibitor Therapy

Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)

Carfilzomib-Induced Tumor Lysis Syndrome and Biventricular Heart Failure in a Patient With Multiple Myeloma

Tocilizumab for CRS Prophylaxis in Haploidentical Peripheral Stem Cell Transplantation

Ponatinib-Induced Cerebrovascular Accident (CVA)

Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome

Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Mutant PPM1D - and TP53 -Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

Early orbital involvement in a rare diagnosis of Burkitt-like lymphoma with 11q aberration

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

Evidence for the Use of Acellular Dermal Matrix in Implant-Based Breast Reconstruction

Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models

Aktive Filter

Suchergebnisse filtern